OptimizeRx Corporation
General ticker "OPRX" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $214.3M (TTM average)
OptimizeRx Corporation follows the US Stock Market performance with the rate: 49.0%.
Estimated limits based on current volatility of 3.6%: low 12.20$, high 13.12$
Factors to consider:
- Total employees count: 117 (+24.5%) as of 2023
- Top business risk factors: History of losses and future profitability concerns, Implementation risks, Strategic risks and growth management, Acquisition/divestiture risks, Geopolitical risks
- Current price 91.9% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.90$, 7.65$]
- 2025-12-31 to 2026-12-31 estimated range: [2.40$, 6.33$]
Financial Metrics affecting the OPRX estimates:
- Positive: with PPE of 7.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.50 > -0.62
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 68.35 > 64.17
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term OPRX quotes
Long-term OPRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $62.45MM | $69.38MM | $92.13MM |
| Operating Expenses | $74.74MM | $95.78MM | $105.83MM |
| Operating Income | $-12.29MM | $-26.40MM | $-13.71MM |
| Non-Operating Income | $0.85MM | $1.24MM | $-5.68MM |
| Interest Expense | $0.00MM | $1.45MM | $6.16MM |
| Income(Loss) | $-11.44MM | $-25.16MM | $-19.39MM |
| Taxes | $0.00MM | $-7.60MM | $0.72MM |
| Profit(Loss)* | $-11.44MM | $-17.57MM | $-20.11MM |
| Stockholders Equity | $126.11MM | $126.55MM | $117.00MM |
| Assets | $134.65MM | $183.37MM | $171.17MM |
| Operating Cash Flow | $10.65MM | $-7.24MM | $4.89MM |
| Capital expenditure | $0.24MM | $0.87MM | $0.11MM |
| Investing Cash Flow | $-58.18MM | $-25.34MM | $-0.45MM |
| Financing Cash Flow | $-18.95MM | $28.22MM | $-4.91MM |
| Earnings Per Share** | $-0.64 | $-1.03 | $-1.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.